| 发明名称 | Bladder cancer diagnosis and/or prognosis method | ||
| 摘要 | A high sensitive and specific non-invasive bladder cancer diagnosis and/or prognosis method based on the detection and quantification of the gene expression of a combination of bladder tumor markers in bladder fluids is provided. A preferred combination of the markers consists of the combination of ANXA10, C14orf78, CTSE, CRH, IGF2, KLF9, KRT20, MAGEA3, POSTN, PPP1R14D, SLC1A6, TERT, ASAM and MCM10 genes. | ||
| 申请公布号 | US9097715(B2) | 申请公布日期 | 2015.08.04 |
| 申请号 | US200712532139 | 申请日期 | 2007.06.05 |
| 申请人 | FINA BIOTECH, S.L.U. | 发明人 | Alcaraz Asensio Antonio;Mengual Brichs Lourdes;Burset Albareda Moises;Ribal Caparros Maria Jose;Ars Criach Elisabet |
| 分类号 | C12Q1/68;G01N33/574 | 主分类号 | C12Q1/68 |
| 代理机构 | Knobbe, Martens, Olson & Bear, LLP | 代理人 | Knobbe, Martens, Olson & Bear, LLP |
| 主权项 | 1. A bladder cancer diagnosis and/or prognosis kit, consisting of a set of probes suitable for the detection and quantification of the expression pattern of the combination of ANXA10, C14orf78, CTSE, CRH, IGF2, KLF9, KRT20, MAGEA3, POSTN, PPP1R14D, SLC1A6, TERT, ASAM and MCM10 genes. | ||
| 地址 | Madrid ES | ||